CFA Voices Support for Legislation to Fix Infant Formula Sector
CFA sent the following letter to congressional leaders asking them to vote for the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (“FDASLA Act”) (S.4348), which would require reforms in how the U.S. Food and Drug Administration regulates infant formula manufacturers, including by setting a minimum inspection frequency. The letter recognizes that the proposed reforms will require additional resources at FDA, and urges members to vote in favor of proposed increases to the FDA food division’s budget set out in House appropriations legislation.
